These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients. Lamberti P; Zoccolella S; Iliceto G; Armenise E; Fraddosio A; de Mari M; Livrea P Mov Disord; 2005 Jan; 20(1):69-72. PubMed ID: 15390046 [TBL] [Abstract][Full Text] [Related]
4. Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective? Kocer B; Guven H; Comoglu SS Biomed Res Int; 2016; 2016():7563705. PubMed ID: 27493964 [TBL] [Abstract][Full Text] [Related]
5. Effect of entacapone on plasma homocysteine levels in Parkinson's disease patients. Nevrly M; Kanovsky P; Vranova H; Langova K; Hlustik P Neurol Sci; 2010 Oct; 31(5):565-9. PubMed ID: 20464572 [TBL] [Abstract][Full Text] [Related]
6. Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study. Postuma RB; Espay AJ; Zadikoff C; Suchowersky O; Martin WR; Lafontaine AL; Ranawaya R; Camicioli R; Lang AE Neurology; 2006 Jun; 66(12):1941-3. PubMed ID: 16801668 [TBL] [Abstract][Full Text] [Related]
7. [Effects of entacapone on plasma homocysteine in Parkinson's disease patients on levodopa]. Zhao P; Yang JF; Liu W; Wang Y; Sun YN; Li Q; Zhang W; Zhang BS Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):512-5. PubMed ID: 23660319 [TBL] [Abstract][Full Text] [Related]
8. The influence of levodopa and the COMT inhibitor on serum vitamin B12 and folate levels in Parkinson's disease patients. Triantafyllou NI; Kararizou E; Angelopoulos E; Tsounis S; Boufidou F; Evangelopoulos ME; Nikolaou C; Vassilopoulos D Eur Neurol; 2007; 58(2):96-9. PubMed ID: 17565222 [TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease: Research puts spotlight on thiamine deficiency and cardiovascular health. Finsterer J; Scorza CA; de Almeida AG; Rodrigues AM; Scorza FA J Clin Neurosci; 2021 Nov; 93():270-271. PubMed ID: 34167881 [TBL] [Abstract][Full Text] [Related]
11. The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status. Zesiewicz TA; Wecker L; Sullivan KL; Merlin LR; Hauser RA Clin Neuropharmacol; 2006; 29(3):106-11. PubMed ID: 16772808 [TBL] [Abstract][Full Text] [Related]
12. Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study. Di Rocco A; Werner P Neurology; 2007 Apr; 68(17):1440; author reply 1440-1. PubMed ID: 17452598 [No Abstract] [Full Text] [Related]
13. Homocysteine in restless legs syndrome. Bachmann CG; Guth N; Helmschmied K; Armstrong VW; Paulus W; Happe S Sleep Med; 2008 May; 9(4):388-92. PubMed ID: 17900981 [TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration. Lamberti P; Zoccolella S; Armenise E; Lamberti SV; Fraddosio A; de Mari M; Iliceto G; Livrea P Eur J Neurol; 2005 May; 12(5):365-8. PubMed ID: 15804266 [TBL] [Abstract][Full Text] [Related]
15. Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients. Nevrly M; Kanovsky P; Vranova H; Langova K; Hlustik P Parkinsonism Relat Disord; 2009 Jul; 15(6):477-8. PubMed ID: 19028438 [No Abstract] [Full Text] [Related]
16. Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis. Dong B; Wu R Clin Neurol Neurosurg; 2020 Jan; 188():105587. PubMed ID: 31733593 [TBL] [Abstract][Full Text] [Related]
17. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis. Xie Y; Feng H; Peng S; Xiao J; Zhang J Neurosci Lett; 2017 Jan; 636():190-195. PubMed ID: 27840145 [TBL] [Abstract][Full Text] [Related]
18. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Rogers JD; Sanchez-Saffon A; Frol AB; Diaz-Arrastia R Arch Neurol; 2003 Jan; 60(1):59-64. PubMed ID: 12533089 [TBL] [Abstract][Full Text] [Related]
19. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients. Camicioli RM; Bouchard TP; Somerville MJ Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534 [TBL] [Abstract][Full Text] [Related]
20. Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications. Zoccolella S; Lamberti P; Armenise E; de Mari M; Lamberti SV; Mastronardi R; Fraddosio A; Iliceto G; Livrea P Parkinsonism Relat Disord; 2005 Mar; 11(2):131-3. PubMed ID: 15734674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]